Companies / Arpelos Biosciences
Arpelos Biosciences
Boston, United States
The company is a privately-held biotech focused on AI-native drug development and immunology.
Arpelos Biosciences, based in Boston, United States, has 2 investors on file, among them Pillar and Wing Venture Capital. Its site turns away automated reads, so VCinfo could not check it; it is listed because an investor's own portfolio page links to it.
Investors
2 investors on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Venture capital | |
| Portfolio page | Venture capital |
More from Pillar
71 companies on its checked portfolioIts portfolio leans to AI & Machine Learning (28%), Healthcare & Biotech (23%), Industrial & Manufacturing (9%).
More from Wing Venture Capital
50 companies on its checked portfolioIts portfolio leans to AI & Machine Learning (35%), Healthcare & Biotech (15%), Cybersecurity (13%).
See Wing Venture Capital's full profile · Who invests alongside it
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get Arpelos Biosciences and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Pillar adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/arpelos.com/investors
# also
GET /v1/companies/arpelos.com
GET /v1/companies/arpelos.com/news